Aintree University Hospitals NHS Foundation Trust was a British public sector healthcare provider responsible for managing the Aintree University Hospital in Fazakerley, Liverpool, England.

During the past decade, University Hospital Aintree conducted 71 clinical trials. In the 10-year time frame, 71 clinical trials started and 28 clinical trials were completed, i.e. on average, 39.4% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 19 clinical trials were completed. i.e. 82.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Hospital Aintree" #1 sponsor was "Liverpool University Hospitals NHS Foundation Trust" with 9 trials, followed by "University College, London" with 7 trials sponsored, "Boehringer Ingelheim" with 5 trials sponsored, "Ipsen" with 4 trials sponsored and "Eli Lilly and Company" with 4 trials sponsored. Other sponsors include 101 different institutions and companies that sponsored additional 87 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital Aintree" #1 collaborator was "Cancer Research UK" with 7 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 6 trials as a collaborator, "University of Liverpool" with 6 trials as a collaborator, "Liverpool University Hospitals NHS Foundation Trust" with 5 trials as a collaborator and "University Hospital Southampton NHS Foundation Trust" with 5 trials as a collaborator. Other collaborators include 118 different institutions and companies that were collaborators in the rest 113 trials.

According to Clinical.Site data, the most researched conditions in "University Hospital Aintree" are "Colorectal Cancer" (6 trials), "Lymphoma" (4 trials), "Systemic Sclerosis" (4 trials), "Anxiety" (3 trials) and "Chronic Obstructive Pulmonary Disease (COPD)" (3 trials). Many other conditions were trialed in "University Hospital Aintree" in a lesser frequency.

Most popular intervention types in "University Hospital Aintree" are "Drug" (81 trials), "Procedure" (29 trials), "Other" (26 trials), "Biological" (16 trials) and "Device" (11 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (24 trials), "capecitabine" (8 trials), "adjuvant therapy" (5 trials), "cyclophosphamide" (5 trials) and "quality-of-life assessment" (5 trials). Other intervention names were less common.

The vast majority of trials in "University Hospital Aintree" are 131 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "University Hospital Aintree". undefined are not yet recruiting, 15 are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 72 completed trials in University Hospital Aintree, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in University Hospital Aintree, 3 "Phase 1" clinical trials were conducted, 31 "Phase 2" clinical trials and 55 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 29 trials that are defined as “Not Applicable".